Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinqiao Yanshu Granules is a traditional Chinese medicine (TCM) formulation currently in Phase II clinical development for the treatment of acute pharyngitis, specifically targeting the Exterior Wind-Heat Syndrome. The drug is administered as granules dissolved in boiling water and is intended to improve symptoms such as pharyngeal pain and signs of inflammation in the throat. The formulation likely contains botanical extracts common in TCM for respiratory and throat conditions, such as *Forsythia suspensa* (Lianqiao) and *Scutellaria baicalensis* (Huangqin). It is being evaluated for its efficacy in shortening the course of the disease and its safety profile in adult patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qinqiao yanshu.